Lockheed Martin Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Lockheed Martin Investment Management's PFE Position: Q4 2025 in Review
Lockheed Martin Investment Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 391,100 shares — an estimated $9.97M sold.
Lockheed Martin Investment Management first reported a position in PFE in Q3 2013 and held it in 20 quarters. The position peaked at $23.6M in Q4 2019. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Lockheed Martin Investment Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Lockheed Martin Investment Management sold 391,100 Pfizer shares in Q4 2025, an estimated $9.97M.
- Lockheed Martin Investment Management first reported a position in Pfizer in Q3 2013 and held it in 20 quarters.
- Lockheed Martin Investment Management's Pfizer position peaked at $23.6M in Q4 2019.
- 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Lockheed Martin Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.